Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.620
+0.030 (0.65%)
At close: Jul 10, 2026, 4:00 PM EDT
4.723
+0.103 (2.23%)
After-hours: Jul 10, 2026, 5:21 PM EDT
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $596.64 million as of July 10, 2026. Its market cap has increased by 41.46% in one year.
Market Cap
596.64M
Enterprise Value
361.90M
1-Year Change
41.46%
Ranking
Category
Stock Price
$4.62
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $596.64M, a decrease of -73.61%. That is a compound annual growth rate of -23.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 596.64M | -7.60% |
| Dec 31, 2025 | 645.72M | -22.76% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
| Jul 23, 2021 | 2.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CeriBell | 743.68M |
| Beta Bionics | 728.58M |
| Tactile Systems Technology | 686.73M |
| Cerus | 620.14M |
| BrainsWay | 606.60M |
| NeuroPace | 583.00M |
| ClearPoint Neuro | 531.71M |
| OrthoPediatrics | 521.15M |